PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today...